RGEN "The settlement size is likely to be considerable, given that the potential peak annual sales for Orencia are estimated at $1 billion in the rheumatoid arthritis market," Piros speculated.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.